Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

Ireland's Shire buys Meritage Pharma for $70m Irish drugmaker Shire has acquired a US-based privately-held company, Meritage Pharma, in a $70m deal that is expected to strengthen its gastrointestinal drugs business. Production & Manufacturing > Manufacturing > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses
Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
News
CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
News

Process & Production

FDA accepts Bristol-Myers' BLA for Opdivo to treat advanced squamous NSCLC
By PBR Staff Writer
The US Food and Drug Administration (FDA) has accepted for filing and review Bristol-Myers Squibb's biologics licensing application (BLA) for Opdivo (nivolumab) to treat patients with advanced squamous non-small cell lung cancer (NSCLC) after prior therapy.
News
Roche gets EMA positive recommendation for Avastin plus chemotherapy to treat cervical cancer
By PBR Staff Writer
Roche has received positive recommendation from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) for the use of Avastin (bevacizumab) in combination with standard chemotherapy to treat adults with persistent, recurrent or metastatic cervical cancer.
News

OTC

Actavis and Medicines360 get FDA approval for pregnancy prevention drug Liletta
By PBR Staff Writer
Irish pharmaceutical firm Actavis and Medicines360 have received approval from the US Food and Drug Administration (FDA) for Liletta (levonorgestrel-releasing intrauterine system) 52mg for use by women to prevent pregnancy for up to three years.
News
Actavis seeks FDA approval to market generic ulcerative colitis drug Uceris
By PBR Staff Writer
Irish specialty pharmaceutical firm Actavis has submitted an abbreviated new drug application (ANDA) to the US Food and Drug Administration (FDA) seeking approval to market Budesonide Extended-release Tablets, 9mg.
News

Manufacturing

Eisai introduces thyroid cancer drug Lenvima in US
By PBR Staff Writer
Japanese pharmaceutical firm Eisai's US subsidiary has launched its in-house developed new anticancer agent Lenvima (lenvatinib mesylate) in the country to treat locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer.
News
GSK completes $20bn three-part asset swap deal with Novartis
By PBR Staff Writer
British drugmaker GlaxoSmithKline (GSK) has completed the $20bn three-part asset swap deal with Switzerland-based pharmaceutical firm Novartis, as part of efforts to dispose of non-core businesses and focus on bolstering core areas.
News